• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Hepatitis B Virus/Hepatitis D Virus-Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid-Positive Allograft and Treated With High-Dose Hepatitis B Immune Globulin.乙型肝炎病毒/丁型肝炎病毒合并感染的肝移植候选者接受乙型肝炎病毒脱氧核糖核酸阳性的同种异体移植物并接受大剂量乙型肝炎免疫球蛋白治疗。
ACG Case Rep J. 2021 May 12;8(5):e00582. doi: 10.14309/crj.0000000000000582. eCollection 2021 May.
2
Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.将乙型肝炎表面抗原阳性肝脏移植给乙型肝炎病毒阳性受者以及丁型肝炎病毒合并感染的作用。
Liver Transpl. 2005 Aug;11(8):922-8. doi: 10.1002/lt.20471.
3
Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipient.HBsAg 阳性肝移植受者的乙型肝炎和丁型肝炎病毒合并感染过程。
Ann Hepatol. 2011 Jul-Sep;10(3):355-60.
4
Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.长期接受最低限度免疫抑制治疗的乙肝表面抗原阳性肝移植受者完全停用乙肝病毒预防措施。
Liver Transpl. 2016 Sep;22(9):1205-13. doi: 10.1002/lt.24493. Epub 2016 Aug 1.
5
Outcomes of liver transplantation in simultaneously hepatitis B surface antigen and hepatitis C virus RNA positive recipients: the deleterious effect of donor hepatitis B core antibody positivity.乙型肝炎表面抗原和丙型肝炎病毒RNA同时阳性受者肝移植的结局：供体乙肝核心抗体阳性的有害影响
Transplant Proc. 2012 Sep;44(7):1960-2. doi: 10.1016/j.transproceed.2012.07.061.
6
Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant.肝移植后第一个月预防乙型肝炎病毒复发的抗乙型肝炎表面抗原免疫球蛋白的最小化：移植时HBsAg定量水平的意义
Transplant Proc. 2014 Sep;46(7):2308-11. doi: 10.1016/j.transproceed.2014.07.043.
7
Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.HIV/HBV 共感染患者中与 delta 肝炎相关的死亡率。
J Hepatol. 2017 Feb;66(2):297-303. doi: 10.1016/j.jhep.2016.10.007. Epub 2016 Oct 14.
8
Recurrence of Hepatitis D Virus in Liver Transplant Recipients With Hepatitis B and D Virus-Related Chronic Liver Disease.乙肝和丁型肝炎病毒相关慢性肝病肝移植受者中丁型肝炎病毒的复发
Transplant Proc. 2019 Sep;51(7):2457-2460. doi: 10.1016/j.transproceed.2019.01.163. Epub 2019 Aug 9.
9
Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.肝移植治疗乙型肝炎时，术前使用α干扰素及术后使用乙型肝炎免疫球蛋白后的无复发生长期生存情况。
Ann Surg. 1997 Sep;226(3):356-65; discussion 365-8. doi: 10.1097/00000658-199709000-00015.
10
Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection.比利时乙型肝炎和乙型肝炎 delta 病毒合并感染：一项多中心 BASL 研究。前瞻性流行病学调查及与 HBV 单一感染的比较。
J Med Virol. 2013 Sep;85(9):1513-7. doi: 10.1002/jmv.23653.

引用本文的文献

1
Updates on Recent Advancements in Hepatitis D Virus Treatment.丁型肝炎病毒治疗的最新进展
Viruses. 2025 Aug 10;17(8):1100. doi: 10.3390/v17081100.
2
The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation.抗病毒预防在肝移植中预防乙型肝炎病毒和丁型肝炎病毒复发的作用。
Viruses. 2023 Apr 23;15(5):1037. doi: 10.3390/v15051037.
3
Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.乙型肝炎免疫球蛋白和抗病毒预防乙型肝炎肝移植后复发的建议。
Turk J Gastroenterol. 2021 Sep;32(9):712-719. doi: 10.5152/tjg.2021.21608.

本文引用的文献

1
Chronic hepatitis delta: A state-of-the-art review and new therapies.慢性丁型肝炎：最新研究进展和新疗法。
World J Gastroenterol. 2019 Aug 28;25(32):4580-4597. doi: 10.3748/wjg.v25.i32.4580.
2
Recurrence of Hepatitis D Virus in Liver Transplant Recipients With Hepatitis B and D Virus-Related Chronic Liver Disease.乙肝和丁型肝炎病毒相关慢性肝病肝移植受者中丁型肝炎病毒的复发
Transplant Proc. 2019 Sep;51(7):2457-2460. doi: 10.1016/j.transproceed.2019.01.163. Epub 2019 Aug 9.
3
Update of the statements on biology and clinical impact of occult hepatitis B virus infection.隐匿性乙型肝炎病毒感染的生物学和临床影响的更新声明。
J Hepatol. 2019 Aug;71(2):397-408. doi: 10.1016/j.jhep.2019.03.034. Epub 2019 Apr 18.
4
Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice.病毒性肝炎：美国移植感染病学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13514. doi: 10.1111/ctr.13514. Epub 2019 Apr 14.
5
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.慢性乙型肝炎的预防、诊断和治疗最新进展：美国肝病研究学会2018年乙型肝炎指南
Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800.
6
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature.来自乙肝表面抗原阳性供体的肝移植：文献综述
World J Gastroenterol. 2016 Sep 21;22(35):8010-6. doi: 10.3748/wjg.v22.i35.8010.
7
Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.从乙型肝炎病毒阳性供体中进行实体器官移植：受者管理共识指南。
Am J Transplant. 2015 May;15(5):1162-72. doi: 10.1111/ajt.13187. Epub 2015 Feb 23.
8
High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.高遗传屏障核苷（酸）类似物预防肝移植后乙型肝炎病毒复发的系统评价。
Am J Transplant. 2013 Feb;13(2):353-62. doi: 10.1111/j.1600-6143.2012.04315.x. Epub 2012 Nov 8.
9
Liver transplantation in delta virus infection.肝移植治疗δ 病毒感染。
Semin Liver Dis. 2012 Aug;32(3):245-55. doi: 10.1055/s-0032-1323630. Epub 2012 Aug 29.
10
Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipient.HBsAg 阳性肝移植受者的乙型肝炎和丁型肝炎病毒合并感染过程。
Ann Hepatol. 2011 Jul-Sep;10(3):355-60.

乙型肝炎病毒/丁型肝炎病毒合并感染的肝移植候选者接受乙型肝炎病毒脱氧核糖核酸阳性的同种异体移植物并接受大剂量乙型肝炎免疫球蛋白治疗。

Hepatitis B Virus/Hepatitis D Virus-Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid-Positive Allograft and Treated With High-Dose Hepatitis B Immune Globulin.

作者信息

Hammami Muhammad Baraa, Kohli Ruhail, Woreta Tinsay, Sulkowski Mark S, Hamilton James P, Toman Lindsey, Saberi Behnam, Laurin Jacqueline, Wang Jacqueline Garonzik, Philosophe Benjamin, Cameron Andrew M, Gurakar Ahmet

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

出版信息

ACG Case Rep J. 2021 May 12;8(5):e00582. doi: 10.14309/crj.0000000000000582. eCollection 2021 May.

DOI:10.14309/crj.0000000000000582
PMID:34549060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8443809/
Abstract

Liver transplantation (LT) for patients with hepatitis D virus (HDV) and hepatitis B virus (HBV) coinfection is uncommon in the United States. Previous case reports described poor outcomes when hepatitis B surface antigen (HBsAg)-positive grafts are transplanted in HBV/HDV-coinfected recipients. However, LT from an HBsAg-negative/HBV-deoxyribonucleic acid-positive donor in an HBV/HDV-coinfected recipient has not been reported. We describe the clinical course and management of an HBV/HDV-coinfected recipient who had LT from an HBsAg-negative/HBV-deoxyribonucleic acid-positive deceased donor and was treated with high-dose hepatitis B immune globulin in combination with an oral tenofovir alafenamide.

摘要

在美国，对丁型肝炎病毒（HDV）和乙型肝炎病毒（HBV）合并感染的患者进行肝移植（LT）并不常见。先前的病例报告描述了在HBV/HDV合并感染的受者中移植乙型肝炎表面抗原（HBsAg）阳性移植物时预后较差。然而，尚未有关于在HBV/HDV合并感染的受者中使用HBsAg阴性/HBV脱氧核糖核酸阳性供体进行肝移植的报道。我们描述了一名HBV/HDV合并感染的受者的临床过程及管理情况，该受者接受了来自HBsAg阴性/HBV脱氧核糖核酸阳性脑死亡供体的肝移植，并接受了大剂量乙型肝炎免疫球蛋白联合口服替诺福韦艾拉酚胺治疗。